在体外治疗中准黑色素受体分子的循环效应
Kaitlyn Chhe1, Maya S Hegde2, Stephanie R Taylor3
1Department of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA.
黑色素和MT1逆agonist通过改变基因表达周期和阶段来影响细胞昼夜节律,独立于SCN. 这些发现凸显了体外模型在研究昼夜生物学的有用性.
科学领域:
- 时间生物学 时间生物学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 昼夜节律调节重要的生理和细胞过程,维持恒常状态.
- 黑色素,一个关键的昼夜调节器,通过黑色素受体1 (MT1) 起作用,主要研究在上神经核 (SCN).
- 在SCN之外的MT1表达表明黑激素在昼夜调节中的作用更广泛.
研究的目的:
- 使用体外模型研究黑激素和MT1逆agonist (UCSF7447) 对细胞昼夜节律的影响.
- 为了确定MT1向分子是否影响昼夜基因振荡,独立于SCN.
- 为了比较黑激素和UCSF7447在昼夜基因上的相位转移效应.
主要方法:
- 利用U2OS昼夜记者细胞系来监测昼夜基因振荡.
- 向细胞系注射黑素和UCSF7447以评估它们对昼夜节律的影响.
- 分析了关键昼夜基因 (如BMAL1和PER2.2) 的周期和阶段的变化.
主要成果:
- 细胞昼夜节律表现出对MT1向分子的反应,独立于SCN的影响.
- 发现黑激素和UCSF7447都会延长BMAL1和PER2基因振荡的时间.
- 黑色素治疗导致昼夜阶段的延迟,而UCSF7447则提升了它们.
结论:
- 在体外模型对于研究黑激素对昼夜节律的直接影响是有价值的.
- 黑色素对昼夜节律的影响超越SCN,直接影响细胞过程.
- 针对MT1的分子可以差异调节昼夜节律,提供潜在的治疗途径.
更多相关视频
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
06:53Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
相关概念视频
Management of Insomnia
Circadian Rhythms and Gene Regulation
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
